LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 107

Search options

  1. Article ; Online: A PUS7 gene pathogenic variant causing self-injurious behavior, sleep disturbances, and developmental delay: A case report.

    Muda, Alice / Malerba, Laura / Giordano, Lucio / Fazzi, Elisa / Accorsi, Patrizia

    American journal of medical genetics. Part A

    2023  Volume 191, Issue 7, Page(s) 1953–1958

    Abstract: PUS7 gene pathogenic variants cause a deficiency in an RNA-independent pseudouridine synthase, which results in a neurodevelopmental phenotype characterized by various degrees of psychomotor delay, acquired microcephaly, aggressive behavior, and ... ...

    Abstract PUS7 gene pathogenic variants cause a deficiency in an RNA-independent pseudouridine synthase, which results in a neurodevelopmental phenotype characterized by various degrees of psychomotor delay, acquired microcephaly, aggressive behavior, and intellectual disability. Since 2018, PUS7 deficiency has been described in 15 patients with different pathogenic variants but similar clinical phenotypes. We describe the case of a male infant with a homozygous truncating pathogenic variant in the PUS7 gene (c.329_332delCTGA; p.Thr110Argfs*4) who, in addition to the previously mentioned features, displays self-injurious behavior, sleep disturbances and motor stereotypies.
    MeSH term(s) Humans ; Male ; Intellectual Disability/genetics ; Intellectual Disability/pathology ; Microcephaly/diagnosis ; Microcephaly/genetics ; Microcephaly/pathology ; Phenotype ; Self-Injurious Behavior/complications ; Self-Injurious Behavior/genetics ; Sleep
    Chemical Substances PUS7 protein, human (EC 5.4.-)
    Language English
    Publishing date 2023-04-17
    Publishing country United States
    Document type Case Reports
    ZDB-ID 2108614-X
    ISSN 1552-4833 ; 0148-7299 ; 1552-4825
    ISSN (online) 1552-4833
    ISSN 0148-7299 ; 1552-4825
    DOI 10.1002/ajmg.a.63212
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Long-Term Visual and Neurodevelopmental Outcomes in Two Children with Congenital Nystagmus Secondary to Methadone Exposure In utero.

    Galli, Jessica / Loi, Erika / Franzoni, Alessandra / Accorsi, Patrizia / Micheletti, Serena / Pansera, Laura / Fazzi, Elisa

    Neuropediatrics

    2023  Volume 54, Issue 6, Page(s) 412–416

    Abstract: Methadone is used as a substitute for illicit opioids during pregnancy. However, the real effect of this molecule on visual and neurodevelopmental outcomes of the children exposed is not fully understood, since studies considered subjects born to ... ...

    Abstract Methadone is used as a substitute for illicit opioids during pregnancy. However, the real effect of this molecule on visual and neurodevelopmental outcomes of the children exposed is not fully understood, since studies considered subjects born to polydrug-dependent mothers and followed for few months/years. We report the long-term outcomes of two infants with congenital nystagmus solely exposed to methadone in utero. Neurological and neurovisual evaluations were performed every year from the first year of life to 11 years of age. One child was diagnosed with developmental coordination disorder. Both cases presented with ophthalmologic (refractive errors), oculomotor (nystagmus and fixation, smooth pursuit, and saccades dysfunctions), and perceptive problems (reduced visual acuity and contrast sensitivity). While nystagmus and other oculomotor dysfunctions remained stable over time, visual acuity and contrast sensitivity improved; refractive errors worsened and required corrective lenses. Both children showed normal neurodevelopmental and cognitive profile. This report highlights the long-term visual and developmental outcomes of two children exclusively exposed to methadone underlining the possibility of a visual dysfunction and motor coordination disorder. These observations prompt the need to investigate prenatal drug exposure as a cause of congenital nystagmus.
    MeSH term(s) Child ; Female ; Humans ; Infant ; Pregnancy ; Methadone/adverse effects ; Nystagmus, Congenital/chemically induced ; Prenatal Exposure Delayed Effects/chemically induced ; Refractive Errors ; Vision Disorders/chemically induced ; Vision Disorders/diagnosis
    Chemical Substances Methadone (UC6VBE7V1Z)
    Language English
    Publishing date 2023-08-14
    Publishing country Germany
    Document type Case Reports ; Journal Article
    ZDB-ID 573291-8
    ISSN 1439-1899 ; 0174-304X
    ISSN (online) 1439-1899
    ISSN 0174-304X
    DOI 10.1055/s-0043-1771388
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Frequency of SCN2A-related disorder in the regional epilepsy centre of brescia between 2002 and 2021.

    Filippi, Corinna / Milito, Giuseppe / Accorsi, Patrizia / Muda, Alice / Fazzi, Elisa Maria / Martelli, Paola / Riva, Antonella / Giordano, Lucio

    Clinical neurology and neurosurgery

    2023  Volume 234, Page(s) 107983

    Abstract: Objective: SCN2A gene pathogenic variants are associated with a wide phenotypic spectrum, encompassing epilepsy, developmental delay, and autism spectrum disorder. Researches conducted in Denmark have revealed a disease frequency of approximately 1/78, ... ...

    Abstract Objective: SCN2A gene pathogenic variants are associated with a wide phenotypic spectrum, encompassing epilepsy, developmental delay, and autism spectrum disorder. Researches conducted in Denmark have revealed a disease frequency of approximately 1/78,608 (0.0012%) live births in this population. We estimated the frequency of SCN2A-related disorder in the birth cohort of Brescia and its province between 2002 and 2021.
    Methods: Frequency was calculated by ratio between patients with SCN2A pathogenic variant and the total number of live births at the Regional Epilepsy Center of Brescia, between 2002 and 2021. The number of births in Brescia and province was obtained from the Italian National Institute of Statistics (ISTAT).
    Results: A frequency of 11/23,2678 births (0.0047%) was found. In comparison with Danish data, we noticed a higher frequency of the pathogenic variant in our population, even considering the same time frame (0.0035% of subjects born between 2006 and 2014).
    Conclusion: The frequency of SCN2A pathogenic variant among live births in Brescia and its Province between 2006 and 2014 was about three times that of Danish population; this difference was about four times if we consider the period from 2002 to 2021. More studies are needed to further delineate the frequency of SCN2A pathogenic variant in Italian population.
    MeSH term(s) Humans ; Autism Spectrum Disorder/genetics ; Phenotype ; NAV1.2 Voltage-Gated Sodium Channel/genetics ; Epilepsy/epidemiology ; Epilepsy/genetics
    Chemical Substances NAV1.2 Voltage-Gated Sodium Channel ; SCN2A protein, human
    Language English
    Publishing date 2023-09-20
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 193107-6
    ISSN 1872-6968 ; 0303-8467
    ISSN (online) 1872-6968
    ISSN 0303-8467
    DOI 10.1016/j.clineuro.2023.107983
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation.

    Di Ianni, Mauro / Liberatore, Carmine / Santoro, Nicole / Ranalli, Paola / Guardalupi, Francesco / Corradi, Giulia / Villanova, Ida / Di Francesco, Barbara / Lattanzio, Stefano / Passeri, Cecilia / Lanuti, Paola / Accorsi, Patrizia

    Cells

    2024  Volume 13, Issue 2

    Abstract: GvHD still remains, despite the continuous improvement of transplantation platforms, a fearful complication of transplantation from allogeneic donors. Being able to separate GvHD from GvL represents the greatest challenge in the allogeneic transplant ... ...

    Abstract GvHD still remains, despite the continuous improvement of transplantation platforms, a fearful complication of transplantation from allogeneic donors. Being able to separate GvHD from GvL represents the greatest challenge in the allogeneic transplant setting. This may be possible through continuous improvement of cell therapy techniques. In this review, current cell therapies are taken into consideration, which are based on the use of TCR alpha/beta depletion, CD45RA depletion, T regulatory cell enrichment, NK-cell-based immunotherapies, and suicide gene therapies in order to prevent GvHD and maximally amplify the GvL effect in the setting of haploidentical transplantation.
    MeSH term(s) Humans ; Transplantation, Haploidentical ; Cell- and Tissue-Based Therapy ; Fear ; Immunotherapy ; Killer Cells, Natural
    Language English
    Publishing date 2024-01-11
    Publishing country Switzerland
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2661518-6
    ISSN 2073-4409 ; 2073-4409
    ISSN (online) 2073-4409
    ISSN 2073-4409
    DOI 10.3390/cells13020134
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Long-Term Visual and Neurodevelopmental Outcomes in Two Children with Congenital Nystagmus Secondary to Methadone Exposure In utero

    Galli, Jessica / Loi, Erika / Franzoni, Alessandra / Accorsi, Patrizia / Micheletti, Serena / Pansera, Laura / Fazzi, Elisa

    Neuropediatrics

    2023  Volume 54, Issue 06, Page(s) 412–416

    Abstract: Methadone is used as a substitute for illicit opioids during pregnancy. However, the real effect of this molecule on visual and neurodevelopmental outcomes of the children exposed is not fully understood, since studies considered subjects born to ... ...

    Abstract Methadone is used as a substitute for illicit opioids during pregnancy. However, the real effect of this molecule on visual and neurodevelopmental outcomes of the children exposed is not fully understood, since studies considered subjects born to polydrug-dependent mothers and followed for few months/years. We report the long-term outcomes of two infants with congenital nystagmus solely exposed to methadone in utero. Neurological and neurovisual evaluations were performed every year from the first year of life to 11 years of age. One child was diagnosed with developmental coordination disorder. Both cases presented with ophthalmologic (refractive errors), oculomotor (nystagmus and fixation, smooth pursuit, and saccades dysfunctions), and perceptive problems (reduced visual acuity and contrast sensitivity). While nystagmus and other oculomotor dysfunctions remained stable over time, visual acuity and contrast sensitivity improved; refractive errors worsened and required corrective lenses. Both children showed normal neurodevelopmental and cognitive profile. This report highlights the long-term visual and developmental outcomes of two children exclusively exposed to methadone underlining the possibility of a visual dysfunction and motor coordination disorder. These observations prompt the need to investigate prenatal drug exposure as a cause of congenital nystagmus.
    Keywords methadone ; congenital nystagmus ; pregnancy ; neurovisual profile ; children
    Language English
    Publishing date 2023-08-14
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 573291-8
    ISSN 1439-1899 ; 0174-304X
    ISSN (online) 1439-1899
    ISSN 0174-304X
    DOI 10.1055/s-0043-1771388
    Database Thieme publisher's database

    More links

    Kategorien

  6. Article ; Online: Position paper on the use of COVID-19 convalescent plasma: an update.

    Prati, Daniele / Fiorin, Francesco / Berti, Pierluigi / De Silvestro, Giustina / Accorsi, Patrizia / Ostuni, Angelo

    Blood transfusion = Trasfusione del sangue

    2021  Volume 19, Issue 4, Page(s) 277–280

    MeSH term(s) COVID-19/blood ; COVID-19/therapy ; Consensus ; Humans ; Immunization, Passive/standards ; Inpatients ; Italy ; Meta-Analysis as Topic ; Randomized Controlled Trials as Topic ; Treatment Outcome
    Language English
    Publishing date 2021-05-21
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2135732-8
    ISSN 2385-2070 ; 0041-1787 ; 1723-2007
    ISSN (online) 2385-2070
    ISSN 0041-1787 ; 1723-2007
    DOI 10.2450/2021.0150-21
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Repetitive and stereotyped behaviors in neurodevelopmental disorders: an observational analysis of four diagnostic groups.

    Brunetti, Sara / Rossi, Andrea / Galli, Jessica / Gitti, Filippo / Nardocci, Nardo / Giordano, Lucio / Accorsi, Patrizia / Calza, Stefano / Fazzi, Elisa

    Minerva pediatrics

    2022  

    Abstract: Background: Repetitive and Stereotyped Behaviors (ST) are one of the key features of autism spectrum disorder (ASD) and they frequently occur in children with developmental delay/intellectual disability or sensory deprivation, but they are also ... ...

    Abstract Background: Repetitive and Stereotyped Behaviors (ST) are one of the key features of autism spectrum disorder (ASD) and they frequently occur in children with developmental delay/intellectual disability or sensory deprivation, but they are also described in children otherwise typical. This study aims to describe and compare ST in children with different neurodevelopmental disorders and in children having stereotypies but no other medical diagnosis (primary stereotypies).
    Methods: The study sample comprised children with autism spectrum disorder (ASD) developmental delay (DD), severe visual impairment (VI) and primary stereotypies (PS), aged between 2 and 12 years old. The characteristics of the ST (age of onset, frequency, duration, triggers, phenomenology) were collected from their clinical history. The children's caregivers completed the Repetitive Behavior Scalerevised (RBS-R) and the Child Behavior Checklist (CBCL) to assess the ST and to screen for behavioral problems, respectively. Data concerning family history and comorbidity were also collected.
    Results: 87 children (ASD [n=23]; DD [n=21]; VI [n=20]; PS [n=23]) were assessed. Mean age of ST onset was before 24 months in the whole sample. Symptoms usually occurred more than once a day in all groups, but Self-Injurious Behavior (SIB) and ST were reported at higher scores on the RBS-R in Secondary group. Stereotypies lasted less than 5 minutes in all but VI sample, in which lasted longer. Stereotypies of locomotion were mostly reported in ASD, self-injurious behaviors in VI, upper limb stereotypies in PS and DD. Parents reported several repetitive behaviors on the RBS-R, while attention deficit and withdrawn behavior appeared to be the main findings of the sample in the CBCL. Finally, a high number of comorbidities and family history for neurodevelopmental disorders was found in all groups.
    Conclusions: The study showed that some specific patterns of stereotypies could be identified in most groups of disorders. At the same time the behavioral profile of children with stereotypies shows a significant overlap among different groups. These preliminary results suggest that stereotypies are strongly linked to neurodevelopmental disorders, but their association needs to be clarified with further studies.
    Language English
    Publishing date 2022-05-05
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 3062664-X
    ISSN 2724-5780
    ISSN (online) 2724-5780
    DOI 10.23736/S2724-5276.22.06835-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.

    Accorsi, Patrizia / Berti, Pierluigi / de Angelis, Vincenzo / De Silvestro, Giustina / Mascaretti, Luca / Ostuni, Angelo

    Blood transfusion = Trasfusione del sangue

    2020  Volume 18, Issue 3, Page(s) 163–166

    Abstract: Passive immunotherapy with plasma derived from convalescent patients recovering from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that blood establishments are ready to satisfy requests for ... ...

    Abstract Passive immunotherapy with plasma derived from convalescent patients recovering from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that blood establishments are ready to satisfy requests for immune plasma by defining the requirements applicable to plasma donors and the standards for preparation, qualification, storage, distribution, and control of product use. This Position paper aims to give recommendations on the biological characteristics of a plasma preparation from convalescent donors and to support the evaluation of this therapeutic approach in more rigorous investigations.
    MeSH term(s) Antibodies, Viral/adverse effects ; Antibodies, Viral/therapeutic use ; Betacoronavirus/immunology ; Blood Banks/organization & administration ; Blood Banks/standards ; Blood Donors/legislation & jurisprudence ; Coronavirus Infections/therapy ; Europe ; Humans ; Immunization Schedule ; Immunization, Passive/adverse effects ; Immunization, Passive/methods ; Immunization, Passive/standards ; Informed Consent ; Italy ; Pandemics ; Plasma/immunology ; Pneumonia, Viral/therapy
    Chemical Substances Antibodies, Viral
    Keywords covid19
    Language English
    Publishing date 2020-06-11
    Publishing country Italy
    Document type Journal Article ; Practice Guideline
    ZDB-ID 2135732-8
    ISSN 2385-2070 ; 0041-1787 ; 1723-2007
    ISSN (online) 2385-2070
    ISSN 0041-1787 ; 1723-2007
    DOI 10.2450/2020.0124-20
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Impact of Covid-19 epidemic on the activities of a blood centre, transfusion support for infected patients and clinical outcomes.

    Quaglietta, Anna / Nicolucci, Antonio / Posata, Raffaella / Frattari, Antonella / Parruti, Giustino / Accorsi, Patrizia

    Transfusion medicine (Oxford, England)

    2020  Volume 31, Issue 3, Page(s) 160–166

    Abstract: Objectives: We evaluated how the Severe Acute Respiratory disease from Coronavirus 2 (SARS-CoV-2) epidemic impacted transfusion services, transfusion support required by Covid-19 patients and their clinical outcome.: Background: In Italy, the first ... ...

    Abstract Objectives: We evaluated how the Severe Acute Respiratory disease from Coronavirus 2 (SARS-CoV-2) epidemic impacted transfusion services, transfusion support required by Covid-19 patients and their clinical outcome.
    Background: In Italy, the first confirmed case of SARS-CoV-2 infection was registered on 21 February 2020. As of 20 April, about 250 000 cases were registered, 1143 of which were in the province of Pescara.
    Methods: We compared transfusion services provided by the blood centre of Pescara between 1 March and 20 April 2019 and between 1 March and 20 April 2020. We assessed the number and type of blood components donated, those transfused in the various hospital departments and those transfused to Covid-19 patients.
    Results: Compared to 2019, we documented a decrease of 32% in the number of donations. The number of transfusions increased by 139% in the infectious diseases department (IDD), dedicated to Covid-19 patients, and by 76% in the intensive care unit (ICU), whereas it markedly decreased in the other departments. Of 299 patients with Covid-19, 60 were transfused (20.1%). Transfused patients in the ICU were significantly younger than those in IDD and had a lower number of lymphocytes, lower post-transfusion increment of haemoglobin levels and higher D-dimer and C reactive protein values. Mortality rate was 60.7% among transfused patients in the ICU and 39.0% among those in the IDD (p = 0.02).
    Conclusion: The Covid-19 epidemic had a profound impact on transfusion activities. The important blood demand for Covid-19 patients was satisfied because of the reduction in activities in other hospital wards. Covid-19-positive transfused patients showed a very poor prognosis.
    MeSH term(s) Aged ; Aged, 80 and over ; Blood Banks/statistics & numerical data ; Blood Component Transfusion/statistics & numerical data ; Blood Donors/statistics & numerical data ; Blood Transfusion/statistics & numerical data ; COVID-19/epidemiology ; COVID-19/therapy ; Female ; Hemoglobins/analysis ; Humans ; Intensive Care Units/statistics & numerical data ; Italy/epidemiology ; Male ; Middle Aged ; Pandemics ; SARS-CoV-2 ; Treatment Outcome
    Chemical Substances Hemoglobins
    Language English
    Publishing date 2020-12-02
    Publishing country England
    Document type Journal Article
    ZDB-ID 1067989-3
    ISSN 1365-3148 ; 0958-7578
    ISSN (online) 1365-3148
    ISSN 0958-7578
    DOI 10.1111/tme.12742
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.

    Accorsi, Patrizia / Berti, Pierluigi / de Angelis, Vincenzo / De Silvestro, Giustina / Mascaretti, Luca / Ostuni, Angelo

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

    2020  Volume 59, Issue 4, Page(s) 102817

    Abstract: Passive immunotherapy with plasma derived from patients convalescent from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that Blood Establishments are prepared to satisfy requests for immune plasma ...

    Abstract Passive immunotherapy with plasma derived from patients convalescent from SARS-CoV-2 infection can be a promising approach in the treatment of COVID-19 patients. It is important that Blood Establishments are prepared to satisfy requests for immune plasma by defining the requirements applicable to plasma donors and the standards for preparation, qualification, storage, distribution and control of use of the product. This position paper is aimed to give recommendations on biological characteristics of a plasma preparation from convalescent donors and to support the evaluation of this therapeutic approach in more rigorous investigations.
    MeSH term(s) Antibodies, Viral/blood ; Betacoronavirus/immunology ; Blood Component Removal/methods ; Blood Donors ; COVID-19 ; Coronavirus Infections/blood ; Coronavirus Infections/immunology ; Coronavirus Infections/therapy ; Donor Selection/standards ; Humans ; Immune Sera/adverse effects ; Immune Sera/isolation & purification ; Immunization, Passive/adverse effects ; Immunization, Passive/methods ; Pandemics ; Pneumonia, Viral/blood ; Pneumonia, Viral/immunology ; Pneumonia, Viral/therapy ; Product Labeling ; Risk ; SARS-CoV-2
    Chemical Substances Antibodies, Viral ; Immune Sera
    Keywords covid19
    Language English
    Publishing date 2020-05-21
    Publishing country England
    Document type Journal Article ; Practice Guideline ; Review
    ZDB-ID 2046795-3
    ISSN 1878-1683 ; 1473-0502
    ISSN (online) 1878-1683
    ISSN 1473-0502
    DOI 10.1016/j.transci.2020.102817
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top